Almac Group
Almac is a pharmaceutical service provider with over 30 years experience. The company provides a range of services including research and development, pharmaceutical testing and clinical trials as well as the commercialisation of pharmaceutical products. The company has experience in biomarker discovery and development through its partners and through internal R&D.
Almac provides comprehensive support from drug discovery through to scale-up and launch of new drugs. Pharmaceutical development includes pre-formulation of drugs, testing and taking them to market. The company has three chemical trial sites globally, with one in Northern Ireland situated at Craigavon.
The company also specialises in the design and manufacture of drug packaging including blistering, bottling and walleting/carding of pharmaceuticals.
Financial Data
-
30th Sep 18 Source: CRO
- €619.3 million turnover
-
€31.2 million
profit - 4,978 employees
-
30th Sep 17 Source: CRO
- €674.9 million turnover
-
€41.9 million
profit - 4,407 employees
- 10 more years available »
Ranking
By Turnover
(€619.3 million)- 127th in Top Companies
- 16th in Health
By Employees
(4,978)- 44th in Top Companies
- 6th in Health
-
- 4,978
- €619.3 million
Employees
- Alan Armstrong CEO/Managing Director
Latest News
- 9:10pm Merkel rejects eurobonds as euro zone struggles for compromise
- 9:09pm Key EU states agree coronavirus economic rescue - diplomats
- 7:07pm European shares post best week since 2011, focus on EU stimulus
- 5:56pm DAA to cut workers’ pay by 20% as Covid-19 travel bans continue
- 5:56pm DAA to put most of its 3,500 workers on a four-day week